Lymphoma Research Foundation CEO Meghan Gutierrez sat down with Congresswoman Debbie Wasserman Schultz, the author of groundbreaking legislation that would transform the field of survivorship research and increase access to survivorship-related healthcare and services. They discussed the bi-partisan Comprehensive Cancer Survivorship Act, her motivation to author the legislation and the needs of cancer survivors.
Jim Baker and his wife, Pia, bonded over their love of cycling. After Pia passed away from primary central nervous system lymphoma, Jim has found a whole new meaning in their shared hobby as he pedals to support LRF.
Many healthcare professionals get into medicine out of a desire to help people, and Zachary Epstein-Peterson, MD is no exception. In fact, one of the primary factors that led him to focus his career on lymphoma was witnessing the close relationships between doctor and patient during his early rotations, and it’s those deep connections with patients that continue to inform his lymphoma research today.
On December 1, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved BTK inhibitor, pirtobrutinib (Jaypirca, Eli Lilly and Company), for adults with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have received at least two…
Lymphoma Research Foundation Raises Over $1 Million at New York City Gala to Help Eradicate Lymphoma October 6, 2023 – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving…
First Lady of Tennessee, Maria Lee, Shares Her Experience with Lymphoma No one ever thinks they will hear the words, “you have cancer.” Those words rang in my ears just over one year ago, and it’s surreal to know that…
Bob came to LRF out of concern for his son, but he continues to work with and donate to the organization out of admiration for LRF’s impact on lymphoma research. Together, Bob and Michael worked to support Foundation research, advocacy, and LRF Scientific Advisory Board efforts to change lives. Bob hopes his estate gift helps advance cures for lymphoma and ensures a brighter future for other families touched by this blood cancer.
The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and laboratory/translational research.
Lymphoma specialist Lisa Rimsza, MD (Mayo Clinic, Arizona) describes these tests in-depth and how they can help patients understand their lymphoma subtype and become their own best health advocate.
Where Are They Now? Mantle Cell Lymphoma Consortium and Initiative: 20 Years in Review Mantle cell lymphoma (MCL) is a rare, typically aggressive form of non-Hodgkin lymphoma (NHL) which accounts for roughly six percent of all NHL cases in the…
